Skip to content. | Skip to navigation

Personal tools
Log in
Home > Profiles > Joshua Shrout

Joshua Shrout

Joshua D Shrout


Phone: 574-631-1726

Office: 214A Cushing Hall (Mailing address: 156 Fitzpatrick Hall)


Ph.D, University of Iowa, 2002

M.S., Civil and Environmental Engineering, Marquette University, 1998

B.S., Environmental Engineering, Northwestern University, 1994



Post-doc. University of Washington/ University of Iowa—Microbiology (2003-2007)

Post-doc. University of Iowa—Civil and Environmental Engineering (2002-2003)

Current Appointments:

Professor Shrout has been a faculty member in the Department Civil and Environmental Engineering and Earth Sciences since 2007 and a concurrent faculty member in the Department of Biological Sciences since 2010.

Center Affiliations:

Advanced Diagnostics and Therapeutics

Eck Institute for Global Health

Summary of Activities/Interests


The Shrout Research Group investigates "sociomicrobiology" and community actions of bacteria that are important to medicine and the environment. Much of our work researches the development of bacterial biofilms.


Biofilms are surface-associated communities of bacteria. Surprisingly, very few factors that regulate biofilm growth on various surfaces such as human tissue, medical implants, water intake pipes, teeth, soil particles, or even other microorganisms are understood even for "simple" bacteria. We use an interdisciplinary research approach to understand how physical and chemical environmental cues influence biological behavior of biofilms.

Relatedly, our group researches the motility of bacteria on surfaces. Many bacteria, such as the organism Pseudomonas aeruginosa, are capable of controlling their surface motility as an initial step in biofilm development. We are working to understand how bacteria orchestrate their response(s).



Blue-sky Biomedical Projects Launched by New Funding

August 30, 2016

Advanced Diagnostics & Therapeutics (AD&T), a strategic research initiative at the University of Notre Dame, has announced the recipients of its Discovery Fund awards for 2016. Innovative research includes efforts to treat Parkinson’s disease, understand heart disease and strokes, tackle bacterial drug resistance.

New Notre Dame Paper Offers Novel Insights into Pathogen Behavior

December 18, 2014

A new study by a team of researchers that includes University of Notre Dame scientists Joshua Shrout and Mark Alber provides new insights into the behavior of an important bacterial pathogen.